M Ventures: Investing in the Future of Medicine

March 28, 2018
This month, CEO Today had the pleasure to connect with Roel Bulthuis - the Managing Director of M Ventures (previously MS Ventures). The company is the strategic venture capital fund of Merck, which Roel established in 2009. M Ventures’ objective is to invest in innovative technologies and products with the potential to significantly impact Merck‘s […]
Read the full article

About CEO Today

CEO Today Online and CEO Today magazine are dedicated to providing CEOs and C-level executives with the latest corporate developments, business news and technological innovations.

Follow CEO Today

chevron-right-circle